@article{article, title  = {{Correction: Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT)}},

 publisher = {{American Association for Cancer Research (AACR)}},

 url = {{http://dx.doi.org/10.1158/1078-0432.ccr-22-3568 }},

 year = {{2022}},

 month = {{12}},

 author = {{Robertson JFR and Coleman RE and Cheung K-L and Evans A and Holcombe C and Skene A and Rea D and Ahmed S and Jahan A and Horgan K and Rauchhaus P et al}},

 doi = {{10.1158/1078-0432.ccr-22-3568}},

 volume = {{28}},

 journal = {{Clinical Cancer Research}},

 issue = {{24}},

 pages = {{5469-5469}},

 note = {{Accessed on 2025/10/10}}}